570 related articles for article (PubMed ID: 16791039)
1. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
2. Protection against cisplatin-induced ototoxicity by adeno-associated virus-mediated delivery of the X-linked inhibitor of apoptosis protein is not dependent on caspase inhibition.
Chan DK; Lieberman DM; Musatov S; Goldfein JA; Selesnick SH; Kaplitt MG
Otol Neurotol; 2007 Apr; 28(3):417-25. PubMed ID: 17211286
[TBL] [Abstract][Full Text] [Related]
3. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
Huang X; Whitworth CA; Rybak LP
Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
[TBL] [Abstract][Full Text] [Related]
4. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
Wang J; Ladrech S; Pujol R; Brabet P; Van De Water TR; Puel JL
Cancer Res; 2004 Dec; 64(24):9217-24. PubMed ID: 15604295
[TBL] [Abstract][Full Text] [Related]
5. Anti-clarin-1 AAV-delivered ribozyme induced apoptosis in the mouse cochlea.
Aarnisalo AA; Pietola L; Joensuu J; Isosomppi J; Aarnisalo P; Dinculescu A; Lewin AS; Flannery J; Hauswirth WW; Sankila EM; Jero J
Hear Res; 2007 Aug; 230(1-2):9-16. PubMed ID: 17493778
[TBL] [Abstract][Full Text] [Related]
6. AAV-mediated gene transfer of human X-linked inhibitor of apoptosis protects against oxidative cell death in human RPE cells.
Shan H; Ji D; Barnard AR; Lipinski DM; You Q; Lee EJ; Kamalden TA; Sun X; MacLaren RE
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9591-7. PubMed ID: 22039248
[TBL] [Abstract][Full Text] [Related]
7. XIAP-mediated neuroprotection in retinal ischemia.
Renwick J; Narang MA; Coupland SG; Xuan JY; Baker AN; Brousseau J; Petrin D; Munger R; Leonard BC; Hauswirth WW; Korneluk RG; Tsilfidis C
Gene Ther; 2006 Feb; 13(4):339-47. PubMed ID: 16307001
[TBL] [Abstract][Full Text] [Related]
8. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
[TBL] [Abstract][Full Text] [Related]
9. Astragalosides reduce cisplatin ototoxicity in guinea pigs.
Xiong M; He Q; Wang J; Lai H
ORL J Otorhinolaryngol Relat Spec; 2011; 73(3):131-6. PubMed ID: 21494054
[TBL] [Abstract][Full Text] [Related]
10. Cochlear protection against cisplatin by viral transfection of X-linked inhibitor of apoptosis protein across round window membrane.
Jie H; Tao S; Liu L; Xia L; Charko A; Yu Z; Bance M; Yin S; Robertson GS; Wang J
Gene Ther; 2015 Jul; 22(7):546-52. PubMed ID: 25809464
[TBL] [Abstract][Full Text] [Related]
11. Correlation of increased activities of Na+, K+-ATPase and Ca2+-ATPase with the reversal of cisplatin ototoxicity induced by D-methionine in guinea pigs.
Cheng PW; Liu SH; Hsu CJ; Lin-Shiau SY
Hear Res; 2005 Jul; 205(1-2):102-9. PubMed ID: 15953519
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein 70 and cellular disturbances in cochlear cisplatin ototoxicity model.
García-Berrocal JR; Nevado J; González-García JA; Sánchez-Rodríguez C; Sanz R; Trinidad A; España P; Citores MJ; Ramírez-Camacho R
J Laryngol Otol; 2010 Jun; 124(6):599-609. PubMed ID: 20307356
[TBL] [Abstract][Full Text] [Related]
13. Inhalation of hydrogen gas attenuates cisplatin-induced ototoxicity via reducing oxidative stress.
Qu J; Li X; Wang J; Mi W; Xie K; Qiu J
Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):111-5. PubMed ID: 22055279
[TBL] [Abstract][Full Text] [Related]
14. Caspase inhibitor facilitates recovery of hearing by protecting the cochlear lateral wall from acute cochlear mitochondrial dysfunction.
Mizutari K; Matsunaga T; Kamiya K; Fujinami Y; Fujii M; Ogawa K
J Neurosci Res; 2008 Jan; 86(1):215-22. PubMed ID: 17722114
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin ototoxicity in the Sprague Dawley rat evaluated by distortion product otoacoustic emissions.
Hatzopoulos S; Di Stefano M; Campbell KC; Falgione D; Ricci D; Rosignoli M; Finesso M; Albertin A; Previati M; Capitani S; Martini A
Audiology; 2001; 40(5):253-64. PubMed ID: 11688544
[TBL] [Abstract][Full Text] [Related]
16. X-Linked inhibitor of apoptosis protein gene-based neuroprotection for the peripheral nervous system.
Garrity-Moses ME; Teng Q; Krudy C; Yang J; Federici T; Boulis NM
Neurosurgery; 2006 Jul; 59(1):172-82; discussion 172-82. PubMed ID: 16823314
[TBL] [Abstract][Full Text] [Related]
17. [Protective and rescue effects of transgenic bFGF/GFP expression mediated by cationic liposome on gentamicin-induced guinea pig cochlear toxicity].
Yin J; Zhai S; Guo W; Hu Y; Shi L
Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1192-4. PubMed ID: 12475408
[TBL] [Abstract][Full Text] [Related]
18. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
Ekborn A; Hansson J; Ehrsson H; Eksborg S; Wallin I; Wagenius G; Laurell G
Laryngoscope; 2004 Sep; 114(9):1660-7. PubMed ID: 15475801
[TBL] [Abstract][Full Text] [Related]
19. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.
Murphy D; Daniel SJ
Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888
[TBL] [Abstract][Full Text] [Related]
20. Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity.
Olgun Y; Kırkım G; Kolatan E; Kıray M; Bagrıyanık A; Olgun A; Kızmazoglu DC; Ellıdokuz H; Serbetcıoglu B; Altun Z; Aktas S; Yılmaz O; Günerı EA
Laryngoscope; 2014 Mar; 124(3):760-6. PubMed ID: 23900991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
